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The Y chromosome gene Sry encodes a transcription factor required to initiate testis development. The related autosomal gene Sox9 is up-
regulated shortly after the onset of Sry transcription and is thought essential for the differentiation of Sertoli cells. The lineage that gives rise
to Sertoli cells has its origins within the coelomic epithelium (CE) of the genital ridge, but from cells also able to give rise to an interstitial cell
type. It was not known at what point SRYacts in the derivation of this lineage or how the two genes interact. To investigate the identity of the
cells expressing Sry, we designed two transgenes driven by the Sry promoter: one gives expression of a stable reporter, human placental
alkaline phosphatase (hPLAP), while the second gives expression of a functional Myc-epitope tagged SRY protein (SRYMYC). Taking
advantage of lasting hPLAP activity after transcription of the reporter gene has ceased, we could show that SryhPLAP was expressed
exclusively in all cells fated to become Sertoli cells. SRYMYC-single-positive cells were first observed in the gonad and not in the CE.
Subsequently, they became SRYMYC/SOX9-double-positive, but only for a few hours before turning into SOX9-single-positive cells. After
the coelomic epithelial cells migrate into the gonad, there is first a decision to become interstitial or supporting cells, and then the transient
expression of SRY in the latter determines their fate as Sertoli cells by up-regulating Sox9.
D 2004 Elsevier Inc. All rights reserved.
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In mammals, the presence of the Y chromosome acts as a
dominant male determinant. Sry was identified as the only
gene on the Y chromosome required to initiate male
development because mice or humans carrying deletions
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UK.sex-reversed phenotype (Gubbay et al., 1990; Sinclair et al.,
1990), and a 14-kb genomic fragment of the Sry gene (Fig.
1A) induced male sex reversal when it was introduced into
XX mice as a transgene (Koopman et al., 1991). Sry
encodes a transcription factor with an HMG box DNA-
binding domain, and no direct target gene(s) of SRY have
yet been identified despite being discovered some 13 years
ago. The autosomal gene Sox9, which encodes a related
HMG box-containing factor, is up-regulated specifically in
XY gonads shortly after the onset of Sry transcription and is
thought essential for the differentiation of Sertoli cells (Kent
et al., 1996; Morais da Silva et al., 1996). The lineage that
gives rise to Sertoli cells has its origins within the coelomic
epithelium (CE) of the genital ridge, but from cells also able
to give rise to an interstitial cell type (Karl and Capel, 1998).
It was not known at what point Sry acts in the derivation of
this lineage or how the two genes interact, because Sry
transcripts are no longer present in the testis once it can be274 (2004) 271–279
Fig. 1. Schematic representation of Sry transgenes. (A) 14-kb Sry genomic fragment described previously, which is sufficient for sex reversal (Koopman et al.,
1991). (B) SryMyc was constructed by insertion of six copies of the Myc-epitope tag (pink circles) as an in-frame fusion immediately before the stop codon. (C)
SryhPLAP was constructed by replacing the 5Vhalf of the coding region with the human placental alkaline phosphatase gene (hPLAP) (orange box) with SV40
splice and polyadenylation signals. hPLAP contains a signal peptide sequence (yellow box) on its 5Vend, which allows it to be localized to the plasma
membrane of cells. The untranslated regions and the coding region of Sry are indicated by blue bars and the blue box, respectively. The red box encodes the
HMG box DNA-binding domain. The green box shows a CAG-rich sequence which encodes a glutamine-rich region.
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of the cells expressing Sry, we designed two transgenes
driven by the Sry promoter: one gives expression of a stable
reporter, human placental alkaline phosphatase (hPLAP),
while the second gives expression of a functional Myc-
epitope tagged SRYprotein (SRYMYC). Taking advantage of
lasting hPLAP activity after transcription of the reporter
gene has ceased, we could show that SryhPLAP was
expressed exclusively in all cells fated to become Sertoli
cells. SRYMYC-single-positive cells were first observed in
the gonad and not in the CE. Subsequently, they became
SRYMYC/SOX9-double-positive, but only for a few hours
before turning into SOX9-single-positive cells. Moreover,
we found that Sox9 expression is altered in Sry mutants,
confirming that Sox9 is genetically downstream of Sry. Our
data suggest that there is first a decision to become
interstitial or supporting cells after the coelomic epithelial
cells migrate into the gonad, and then the transient
expression of SRY in the latter determines their fate as
Sertoli cells by up-regulating Sox9.Materials and methods
Construction of plasmids and generating transgenic mice
To generate the SryMyc construct, we introduced a new
XhoI site at the stop codon, position 9490 on the 14-kb 741
genomic clone (Koopman et al., 1991). The XhoI site was
blunt-ended, and a BamHI-StuI fragment containing six
copies of c-Myc tag derived from pCS2 + MT (Roth et al.,1991) was inserted also after being blunt-ended. SryhPLAP
was generated by replacing the EcoRV (8224)–EcoRV
(8712) fragment with the human placental alkaline phos-
phatase gene (Kam et al., 1985) and SV40 small t gene.
Transgenes were released from plasmids by SalI digestion
and injected into pronuclei of fertilized eggs from F1
(C57BL/10  CBA) mice. The injected embryos were
transferred into oviducts of pseudopregnant F1 recipients.
Transgenic mice were identified by PCR using 5V-ATGGA-
GAGCTTGGGCGACCTC-3V and 5V-AATCATAGCAAGQ
GGGGAGTGTTG-3V for SryMyc, and 5V-AGAGCGACATQ
ATGGGAAGCG-3V and 5V-AAGTTTTGACTTCTGTATQ
CTGTCTG-3Vfor SryhPLAP. Sex-reversed XYTdym1 females
(Lovell-Badge and Robertson, 1990) and XYTdym1Sry/+
males were generated by crossing between XYTdym1
females and XYSry/+ males (Mahadevaiah et al., 1998).
In situ hybridization, immunohistochemistry, and alkaline
phosphatase staining
In situ hybridization of Sox9 was described by Morais
da Silva et al. (1996). The full-length hPLAP cDNA
(Kam et al., 1985) was used as a probe for in situ
hybridization of the SryhPLAP transgene. To detect
SRYMYC expression, gonads were fixed with MEMFA
(4% formaldehyde, 1 mM MgCl2, 2 mM EGTA, 100 mM
MOPS, pH 7.4) for 30 min at 48C and subsequently
bleached with 3% H2O2, 0.1% Triton X-100 in PBS for
30 min at room temperature and incubated in PBS
containing 1.5% blocking reagent (Boehringer Man-
nheim), 0.1% Triton X-100 for 60 min. As a primary
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14, Santa Cruz Biotechnologies, Inc.) in 1:200 dilution
and incubated overnight at 48C. After washing and
blocking, anti-rabbit IgG conjugated to peroxidase
(Sigma) was added and incubated overnight at 48C.
Peroxidase activities were detected in 1 mg/ml diamino-
benzidine tetrahydrochloride, 0.03% H2O2, 0.1% Triton
X-100, PBS. For cryosections, after incubation with 30%
sucrose in PBS overnight, gonads were embedded in
O.C.T. compound and sectioned at 10 Am. After
incubation with anti-c-Myc rabbit polyclonal IgG fol-
lowed by 1:350 diluted anti-rabbit IgG conjugated to Cy3
(Amersham Pharmacia Biotech), unbound IgGs were
inactivated by microwaves for 5 min. Sections were
incubated in 1:1000 diluted anti-SOX9 rabbit antiserum
(Morais da Silva et al., 1996) and then 1:200 diluted anti-
rabbit IgG conjugated to Alexa Fluor 488 (Molecular
Probes). To detect alkaline phosphatase activities, we
followed the method described by Ginsburg et al. (1990)
for primordial germ cells and by Sharpe et al. (1998) for
the SryhPLAP transgene.Results and discussion
MYC epitope-tagged SRY causes sex reversal
To investigate Sry action, it is important to know when
and where SRY protein is expressed. However, attempts to
make an antibody against mouse SRY that would allow
immunohistochemistry studies in vivo have failed, while
antibodies raised against human SRY do not cross-react
with the mouse protein because their amino acid sequences
are too different. To circumvent this problem, six copies of
the c-Myc epitope tag were inserted just before the mouse
SRY stop codon in the context of the 14-kb genomic
fragment of the Sry locus (Fig. 1B). The SryMyc transgene
was injected into fertilized eggs and four independent lines,
A–C and E, were generated from XY male founders (see
Supplemental Table 1). A fifth founder, D, was an XX
female, so it was assumed that the transgene was not
sufficiently active to be useful. Male founders were mated
with wild-type females to test if the transgene led to XX
male sex reversal. We observed 100% sex reversal in three
lines, A, B, and E, and 33% in line C (Fig. 2A). Line C
expresses SryMyc at a lower level than in the other lines (data
not shown), consistent with previous studies showing that
dpartialT sex reversal is a consequence of transgene
expression levels below a critical threshold of about 50%
compared to the endogenous Sry gene (Burgoyne et al.,
2001; Capel et al., 1993; Lovell-Badge, 1993; Swain et al.,
1998). In the three lines showing complete sex reversal,
adult testes of XX SryMyc mice were smaller than those of
XY SryMyc mice (Figs. 2B, C) or wild-type males (data not
shown) because the presence of two X chromosomes is
incompatible with spermatogenesis (Lyon et al., 1981). Inembryonic testes, however, testis cord formation was
apparent in XX gonads and showed no delay in comparison
with XY gonads of the same development stage as judged
by tail somite number (data not shown). These data show
that the MYC epitope tag does not interfere with SRY
function in vivo.
Expression of SRYMYC protein during gonadal development
Studies using RNAse protection assays, RT–PCR, and
in situ hybridization all show the presence of mouse Sry
transcripts, specifically within the developing genital
ridge, during a fairly narrow time window (Bullejos
and Koopman, 2001; Hacker et al., 1995; Jeske et al.,
1995; Swain et al., 1998). This starts at the 11–12-tail
somite stage (ts), corresponding on average to a few
hours after 10.5 days postcoitum (dpc), reaches a peak at
18 ts (11.5 dpc), and declines towards 27 ts (shortly
before 12.5 dpc). However, it has been difficult to
unambiguously identify the cell type in which these
transcripts appear. To investigate the expression of the
SryMyc transgene, we used an anti-MYC antibody and
performed immunostaining during gonadal development,
focusing on lines C and E. At 8 ts, (10.5 dpc on
average), there were no cells positive for SRYMYC. The
protein was first detected at 12 ts in a few cells located
below the epithelium in the central region of both XY
and XX gonads of lines C (Fig. 5A) and E (data not
shown). At 18 ts, SRYMYC expression was seen in cells
scattered throughout the gonads, again in both lines C
(Figs. 2D, E) and E (Figs. 2F, G). In the testes of XY
and XX sex-reversed mice, the expression was absent at
30 ts (corresponding on average to 12.5 dpc), (Fig. 2H).
Double labeling for alkaline phosphatase activity showed
that there was no expression of SRYMYC in germ cells
(see Supplemental Fig. 1), which is in contrast to the
situation in humans (Salas-Corte´s et al., 1999). These
expression data agree with previous studies looking at Sry
transcripts (Bullejos and Koopman, 2001; Hacker et al.,
1995; Jeske et al., 1995; Swain et al., 1998), with very little
delay in the first appearance and final loss of the protein
compared to mRNA. This is consistent with efficient
translation and with the protein having a short half-life.
There was no qualitative difference between lines C and E,
with similar numbers of cells expressing SRYMYC at all
stages examined. However, in line C, where the transgene
often failed to sex-reverse XX embryos due to its lower
level of expression, SRYMYC was still present in ovaries at
30 ts (Fig. 2I) and subsequently up to 14 dpc (data not
shown). These results suggest that there is a negative
feedback mechanism for turning off Sry transcription, but
only if the levels of SRY protein reach above the critical
threshold required to initiate testis development. This is
consistent with previous findings from Lee and Taketo
(1994) where expression of Sry was prolonged in sex-
reversed ovaries/ovotestes in embryos carrying a weak allele
Fig. 2. Sex-reversed phenotype of SryMyc transgenic mice and the expression of SRYMYC protein. (A–C) Eleven-week-old litters derived from line E were
analyzed for sex-reversed phenotype. External genitalia with male character was seen in an XX SryMyc transgenic mouse (left) comparing with a wild-type XX
female (right) (A). XX SryMyc testis (B) were smaller than XY SryMyc testis (C) because of lack of sperm in XX testes. (D–I) The embryonic gonads were
dissected from the incompletely penetrant line C (D, E and H, I) and a completely penetrant line E (F, G). At 18 ts, expression was observed throughout both
XY (D) and XX (E) indifferent gonads in line C. No significant differences were seen in either XY (F) or XX (G) indifferent gonads in line E. At 30 ts, the
expression was barely detectable in XY testes (H). In the case of non-sex-reversed XX SryMyc females in line C, expression was maintained in the ovaries (I).
Scale bars, 1 mm. Abbreviations: e indicates epididymis; g, gonad; m, mesonephros; t, testis.
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cases, SRY fails to reach above a particular threshold.
SRYhPLAP is expressed exclusively in the Sertoli cell lineage
From direct cell lineage studies using DiI, it was found
that descendents of cells within the CE can migrate into the
gonads in both sexes, and it was possible to follow their fate
in the testes (Karl and Capel, 1998). At early stages (before
18 ts), the labeled cells have the potential to give at least
three different cell types: Sertoli cells within the testis cords,
an interstitial cell type of unknown identity, and tunica cells
when they remain in the CE. At later stages (post-18 ts),
cells within the CE appear to have lost the ability to
contribute to Sertoli cells, although it is possible that they
are physically excluded from the cords and, being in the
wrong environment, differentiate into the interstitial cell
type or die. Since SRYMYC is no longer found in the testis at
a time when the various somatic cell types can be identified,the question remains as to whether expression of the gene is
restricted to the precursors of Sertoli cells, or whether it can
also be found in other lineages. To overcome this problem,
we replaced a part of the coding region of Sry with that of
the human placenta alkaline phosphatase (hPLAP) gene,
also in the context of the 14-kb genomic fragment of Sry, to
give SryhPLAP, (Fig. 1C). The human enzyme is stable, even
at high temperature, and its activity is known to persist for
some time after transcription is turned off. This should
enable us to trace the cell lineage in which the transgene was
expressed. Three out of three transgenic mouse lines showed
expression of the hPLAP transcript specifically within the
genital ridge at 18 ts, but not at 30 ts. This was shown by in
situ hybridization (Figs. 3A–D) and by RT–PCR (data not
shown), confirming that expression of the transgene mir-
rored that of the endogenous gene. In contrast, hPLAP
activity from the transgene, which was also readily detected
at 18 ts, was retained strongly at 30 ts in XY embryos (Fig.
3F). It should be noted that endogenous alkaline phospha-
Fig. 3. Sertoli cell lineage-specific expression of the SryhPLAP transgene. (A–D) In situ hybridization with SryhPLAP transgene showed that the hPLAP transcript
is strongly expressed in XY gonads from the transgenic mice (B) but not from wild-type mice (A) at 18 ts. The expression level of the transcript decreases in
XY gonads at 24 ts (C) and is hardly detectable at 30 ts (D). (E–G) However, enzyme activity from SryhPLAP transgene is prominent throughout testis cords of
an XY SryhPLAP male at 30 ts (F). Before the detection of hPLAP activity, endogenous alkaline phosphatase activity is inactivated by heat treatment at 658C, so
shown by the absence of staining in testes of wild-type XY mice at this stage (E). The gonad shown in (F) was sectioned to confirm that SryhPLAP activity was
detected at the plasma membrane of cells only in the testis cords (G). (H) A section of a XY SryhPLAP testis cord double-stained for SOX9 protein (green signal
in nuclei) and SryhPLAP activities (red signal at plasma membrane) showed that they colocalize in the same cells (left). The same section was viewed with DAPI
staining (blue) and SryhPLAP activity (right). Scale bars, 1 mm. Abbreviations: g indicates gonad; k, kidney; m, mesonephros.
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completely inactivated by the heat treatment used in the
protocol (Fig. 3E).
At 30 ts, the structure of the testis and many of the cell
types can be recognized morphologically. SRYhPLAP was
detected only within testis cords and not in interstitial cells of
XY transgenic embryos (Fig. 3G). The cords contain PGCs
and Sertoli cells. Given that the PGCs did not express SryMyc
(see above), they are also unlikely to express SryhPLAP. In the
context of the gonad, SOX9 is a very good marker of Sertoli
cells, at least after 18 ts when they can also be identified by
morphological criteria (Kent et al., 1996; Morais da Silva
et al., 1996). Using specific antibodies to SOX9, we find that
all cells positive for hPLAP activity, which is localized to the
plasma membrane, also show nuclear staining for SOX9 andvice versa (Fig. 3H). SRY therefore acts uniquely within the
supporting cell lineage to direct their fate to that of Sertoli
cells, and in a normal situation, there is no recruitment of cells
that have not expressed Sry into this lineage. This is in
contrast to the results of Burgoyne et al. (Burgoyne et al.,
1988; Palmer and Burgoyne, 1991) and Patek et al. (1991),
who found that some XX cells could differentiate as Sertoli
cells in XX-XY chimaeras. It is possible that the XX cells
acquire a Sertoli cell phenotype relatively late in these cases
and/or that the presence of cells of the correct lineage can be
recruited to differentiate as Sertoli cells even if they do not
contain Sry, whereas in our case, all cells contain Sry and the
SryhPLAP transgene.
Albrecht and Eicher (2001) also used a transgenic
approach to explore Sry expression and gonadal cell
Fig. 4. Sox9 expression is altered in indifferent gonads of Sry mutants. XY
mice carrying the Tdym1 mutation are fertile sex-reversed females due to an
11-kb deletion of the Y chromosome encompassing the Sry gene. This sex
reversal can be drescuedT by breeding in an autosomal Sry transgene, which
gives fertile male mice that are XYTdym1Sry/+. Crosses between
XYTdym1Sry/+ males and wild-type XX females gives rise to wild-type
XY males and XX females and to XYTdym1 null mutant female and XXSry/
+ transgenic male. (A–D) In situ hybridization for 18 ts indifferent gonads
shows that Sox9 is expressed in wild-type XY male (A) but not XX female
(B). In XYTdym1 female, Sox9 expression is totally abolished (C). On the
other hand, it is induced in XXSry/+ male (D). Scale bars, 1 mm.
Abbreviation: m indicates mesonephros.
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Sry was used to drive expression of an EGFP reporter
gene. However, Sryegfp transcription was not down-
regulated appropriately by 12.5 dpc (30 ts), and transcripts
were still present at 15.5 dpc and even postnatally at P1
and P28, while EGFP could be detected as late as
15.5 dpc. It was concluded that Sry is expressed in the
supporting cell lineage, and our data agree with this, but
continual transcription strictly precludes use of this
transgene as a lineage marker. A comparison of their
results with ours indicates that the region 3V to Sry must
contain essential information for its correct regulation.
This is consistent with our own unpublished data, where
5V sequences alone are unable to drive correct expression
of reporter genes, including hPLAP and with data
obtained by Jo Bowles and Peter Koopman (personal
communication), who were able to delete all sequences 5V
to the transcriptional start site and still efficiently obtain
XX male sex reversal.
Sox9 is genetically downstream of Sry
Sox9 is expressed at very low levels in the genital ridge
of both sexes at 10.5 dpc. By 11.5 dpc, however, Sox9
expression has become strongly up-regulated in the male
gonad (Fig. 4A), while it is down-regulated in the female
(Fig. 4B) (Kent et al., 1996; Morais da Silva et al., 1996).
Sox9 expression appears to be abolished in mice lacking the
+KTS isoform of WT1, equivalent to Frasier syndrome in
humans (Hammes et al., 2001), and also in Sf-1/ mice
(Swain, Guioli, and L-B, unpublished data). Therefore, both
WT1 and SF-1 may well be required to initiate Sox9
expression. Since the up-regulation of Sox9 closely follows
the onset of Sry expression, and since it appears to have a
critical role in sex determination, Sox9 has been thought to
be a good candidate for a direct target gene of SRY (Lovell-
Badge et al., 2002). Further genetic evidence that Sox9
expression depends on SRY rather than an on another Y-
linked gene or an X chromosome dosage effect was
obtained by finding that its expression was absent from
genital ridges of XYTdym1 embryos (Lovell-Badge and
Robertson, 1990; Mahadevaiah et al., 1998), which lack
Sry (Fig. 4C) but present at a high level in those of XX
embryos carrying a sex-reversing Sry transgene (Fig. 4D).
There is considerable evidence from both loss and gain of
function mutations that Sox9 is required for male develop-
ment. Haploinsufficiency of the SOX9 gene in humans
causes the skeletal malformation syndrome, campomelic
dysplasia with approximately 75% of XY patients also
showing male-to-female sex reversal (Foster et al., 1994;
Kwok et al., 1995; Preiss et al., 2001; Wagner et al., 1994),
furthermore, homozygous loss of Sox9 in mice leads to XY
ovary development (Chaboissier et al., 2004). In contrast, an
XX individual with a duplication of 17q23–24 containing
SOX9 showed female-to-male sex reversal (Huang et al.,
1999). In mice, the insertion of a tyrosinase minigene 1 Mbupstream of Sox9 (and an associated 100-kb deletion) leads
to constitutive activation of Sox9 within the gonad.
Consequently, all these transgenic mice, named Odsex
(Ods), can develop as males irrespective of the presence of
Sry (Bishop et al., 2000). Moreover, it was reported recently
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gave rise to female-to-male sex reversal in transgenic mice
(Vidal et al., 2001). All these findings suggest that Sox9 is
the only critical gene downstream of SRY, which adds
weight to the suggestion that it is a direct target.
SRYMYC and SOX9 are transiently colocalized in Sertoli cell
precursors
If SRY up-regulates Sox9 expression directly, they
would need to be coexpressed earlier than 30 ts, within
the Sertoli cell lineage. To test this, we used antibodies
against both SOX9 and the MYC epitope on sections of
genital ridges of SryMyc transgenic embryos. Neither
protein was detectable at 11 ts (data not shown). A few
SRYMYC-positive cells were first found at 12 ts, but SOX9
was still undetectable at this stage (Fig. 5A). At 18 ts, there
were more SRYMYC-positive cells, but most of these were
now also positive for SOX9. However, many cells were
seen at this stage that were positive for SOX9 alone (Fig.
5B). Subsequently, the proportion of SRYMYC-positive
cells decreased, and most cells in the gonad became
SOX9-positive by 25 ts (Fig. 5C). A rough estimate of the
relative proportion of cells that were single or double-
positive for the two proteins was obtained by comparing
these cells with the total number of cells in the sections
shown in Fig. 5. Thus, at 18 ts, approximately 4% of cells
were positive for SRY alone, 14% were double-positive,
and 18% just expressed SOX9. At 25 ts, the relative
proportions being 2% SRYMYC-single-positive, 6% double-
positive, and 50% SOX9-single-positive. To be consistent
with our conclusions reached above, that all SRY-positive
cells become Sertoli cells, we assume that the SOX9-
single-positive cells were the descendents of cells that had
once been SRYMYC-positive. This implies that the lifetime
of SRYMYC protein is very short in each cell and probably
substantially less than the 14-h time difference between 12
and 18 ts embryos. As we see SOX9-single-positive cellsFig. 5. Colocalisation of SRYMYC and SOX9 proteins during male gonadal
development. The gonads derived from XYSryMyc males were immunos-
tained for SRYMYC (red) and SOX9 (green) with DAPI (blue). (A) At 12 ts,
a few SRYMYC-positive cells (red) were observed directly underneath, but
not at the CE. SOX9-positive cells were not detected in these conditions.
(B) At 18 ts, SRYMYC-positive cells were not only directly underneath the
CE but also further inside the gonads. Approximately 78% of SRYMYC-
positive cells were SOX9-positive as well (yellow) and 56% of SOX9-
positive cells were already SOX9-single-positive at this stage. (C) At 25 ts,
the population of SRYMYC-positive cells decreased while SOX9-positive
cells occupied major parts of the gonad. SRYMYC-single-positive cells,
presumably newly migrated into the gonad, were still observed. (D–G) A
merged image of a double-positive cell (G) at 18 ts showing SRYMYC (E)
and SOX9 (F) colocalized within the nucleus. DAPI strongly stains
heterochromatin regions (D). Neither SRYMYC nor SOX9 were expressed in
these regions. The same colocalization pattern was observed from 14 to 25
ts (data not shown). Abbreviations: ce indicates coelomic epithelium; m,
mesonephros.by 15 ts, this suggests that SRY can be present for no more
than 7 h (i.e., the time difference between 12 and 15 ts).
Human SRY has been reported to be present in the
cytoplasm of some cells in the early genital ridge (Harley,
2002) and also reported to be expressed in a nuclear speckle
pattern implicating a role in pre-mRNA splicing (Ohe et al.,
2002). However, we could not detect SRYMYC in either the
cytoplasm or nuclear speckles at any stage (Figs. 5D, E).
With respect to SOX9, some of this present data contrast
with our earlier expression studies showing that Sox9
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gonads before 12 ts, before the initiation of Sry expression
in males (Morais da Silva et al., 1996). Moreover, it has
been reported that SOX9 protein is cytoplasmic in the very
early genital ridges of both sexes in both mouse and human
(Barbara et al., 2000; Morais da Silva et al., 1996), but we
were unable to detect SOX9 in the cytoplasm at any stage
because the first time we detect SOX9 expression is in cells
that are also positive for SRYMYC (Figs. 5E–G). In the
present study, C57BL/10  CBA hybrid mice were used
instead of the outbred strain (Parkes) looked at previously,
and the expression level of Sox9 may be background-
dependent. We may also have lost sensitivity using both a
different aliquot of anti-SOX9 antibody and through double
staining for the MYC-epitope.Conclusions
In the experiments reported here, we show precisely
when and which cell types SRY is active, and for how
long. Several cellular events that depend on SRY activity
have been described. Thus, SF-1-positive cells within the
CE show an increase in proliferation during the period
when Sry is maximally expressed (Schmahl et al., 2000)
and mesonephric cells migrate into the gonads and
contribute to the peritubular myoid cells and endothelial
cells of the vasculature (Capel et al., 1999). Our findings
together with those of others allow a model to be proposed
that links the action of SRY and SOX9 (see Supplemental
Fig. 3). In agreement with studies looking for Sry tran-
scripts, we found no expression of either SryMyc or SryhPLAP
within cells of the CE at any stage. This clearly indicates
that SRY does not act within the precursors of the three
gonadal cell types, namely, the SF-1-positive cells within
the CE. As a result of cell division within the CE, cells enter
the genital ridge where they undergo a further asymmetric
cell division, where one daughter will become an interstitial
cell while the other becomes a supporting cell precursor.
The latter may express Sox9 at a low level. As there was no
hPLAP expression in any interstitial cell type, we can
conclude that Sry expression is initiated only after cells have
made the cell-fate decision to become supporting cell
precursors. Sry begins to be expressed only in these cells,
and once its protein product has accumulated above a
threshold, Sox9 expression is up-regulated. This leads not
only to Sry itself being turned off in that cell, but also to the
production of a signal back to the CE to stimulate
proliferation and further recruitment of cells into the genital
ridge, initiating the cycle over again. Once sufficient, Sertoli
cells have begun to differentiate; a further signal permits
migration of cells from the underlying mesonephros, which
enter the genital ridge and differentiate as endothelial cells
and as peritubular myoid cells around the forming Sertoli
cell cords. Since overexpression of SOX9 is enough to
induce testis differentiation, it can clearly mediate all thedownstream events, but a brief pulse of SRY is normally
required to set the ball rolling.Acknowledgments
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